m7GDisAI: N7-methylguanosine (m7G) sites and diseases associations inference based on heterogeneous network
暂无分享,去创建一个
Bowen Song | Jiani Ma | Lin Zhang | Jin Chen | Chenxuan Zang | Hui Liu | Hui Liu | Lin Zhang | Jiani Ma | B. Song | Jin Chen | C. Zang
[1] Dong-Hyun Kim,et al. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. , 2005, Gynecologic oncology.
[2] Deendayal Dinakarpandian,et al. Finding disease similarity based on implicit semantic similarity , 2012, J. Biomed. Informatics.
[3] Arash Salmaninejad,et al. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles , 2020, Cellular Oncology.
[4] By Yasuhiro,et al. Discovery of m 7 Gcap in eukaryotic mRNAs , 2015 .
[5] Fowzan S. Alkuraya,et al. Mutation in WDR4 impairs tRNA m7G46 methylation and causes a distinct form of microcephalic primordial dwarfism , 2015, Genome Biology.
[6] A. J. Shatkin,et al. 5′-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation , 1975, Nature.
[7] Lulu Hu,et al. Transcriptome-wide Mapping of Internal N7-Methylguanosine Methylome in Mammalian mRNA. , 2019, Molecular cell.
[8] E. Phizicky,et al. Two-subunit enzymes involved in eukaryotic post-transcriptional tRNA modification , 2014, RNA biology.
[9] K. Entian,et al. Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function , 2016, RNA biology.
[10] Samie R Jaffrey,et al. An expanding universe of mRNA modifications , 2014, Nature Structural &Molecular Biology.
[11] Junwei Shi,et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control , 2017, Nature.
[12] Prateek Jain,et al. Low-rank matrix completion using alternating minimization , 2012, STOC '13.
[13] Y. Furuichi,et al. Discovery of m7G-cap in eukaryotic mRNAs , 2015, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[14] Jiajie Peng,et al. SemFunSim: A New Method for Measuring Disease Similarity by Integrating Semantic and Gene Functional Association , 2014, PloS one.
[15] Dave Zachariah,et al. Alternating Least-Squares for Low-Rank Matrix Reconstruction , 2012, IEEE Signal Processing Letters.
[16] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[17] R. Berkowitz,et al. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. , 2000, The American journal of pathology.
[18] J. Engelman,et al. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. , 2014, Cancer cell.
[19] K. Shimotohno,et al. Importance of 5'-terminal blocking structure to stabilize mRNA in eukaryotic protein synthesis. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[20] Victor S Lelyveld,et al. Mettl1/Wdr4-Mediated m7G tRNA Methylome Is Required for Normal mRNA Translation and Embryonic Stem Cell Self-Renewal and Differentiation. , 2018, Molecular cell.
[21] Jia Meng,et al. m7GHub: deciphering the location, regulation and pathogenesis of internal mRNA N7-methylguanosine (m7G) sites in human , 2020, Bioinform..
[22] V. Cowling,et al. Regulation of mRNA cap methylation , 2009, The Biochemical journal.
[23] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[24] M. Koike,et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer , 1997, Nature Genetics.
[25] Jionglong Su,et al. WHISTLE: a high-accuracy map of the human N6-methyladenosine (m6A) epitranscriptome predicted using a machine learning approach , 2019, Nucleic acids research.
[26] D. Alberts,et al. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] Philip S. Yu,et al. A new method to measure the semantic similarity of GO terms , 2007, Bioinform..
[28] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[29] R. Wood,et al. Dual role for mammalian DNA polymerase ζ in maintaining genome stability and proliferative responses , 2013, Proceedings of the National Academy of Sciences.
[30] P. Moore,et al. The crystal structure of yeast phenylalanine tRNA at 1.93 A resolution: a classic structure revisited. , 2000, RNA.
[31] M. Olivier,et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.
[32] Philip Resnik,et al. Using Information Content to Evaluate Semantic Similarity in a Taxonomy , 1995, IJCAI.
[33] Samie R Jaffrey,et al. Reading, writing and erasing mRNA methylation , 2019, Nature Reviews Molecular Cell Biology.
[34] R. Roskoski. The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.
[35] J. Coward,et al. A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients , 2020, European Journal of Clinical Pharmacology.
[36] Yun-Gui Yang,et al. Dynamic methylome of internal mRNA N7-methylguanosine and its regulatory role in translation , 2019, Cell Research.
[37] Galit Lahav,et al. Stimulus-dependent dynamics of p53 in single cells , 2011, Molecular systems biology.
[38] H. Grönberg,et al. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome , 2005, Clinical genetics.
[39] D. Stern,et al. Specificity within the EGF family/ErbB receptor family signaling network , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[40] E. Izaurralde,et al. The role of the cap structure in RNA processing and nuclear export. , 1997, European journal of biochemistry.
[41] D. Ward,et al. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.
[42] Yadong Wang,et al. DisSetSim: an online system for calculating similarity between disease sets , 2016, Journal of Biomedical Semantics.
[43] C. Che,et al. Gold(III) complexes inhibit growth of cisplatin-resistant ovarian cancer in association with upregulation of proapoptotic PMS2 gene , 2014 .
[44] I. Vlodavsky,et al. Expression of heparanase, Mdm2, and erbB2 in ovarian cancer. , 2001, International journal of oncology.
[45] J. Armstrong,et al. The effect of capping and polyadenylation on the stability, movement and translation of synthetic messenger RNAs in Xenopus oocytes. , 1985, Nucleic acids research.
[46] Tom Fawcett,et al. An introduction to ROC analysis , 2006, Pattern Recognit. Lett..
[47] Anna Tramontano,et al. Accurate energies of hydrogen bonded nucleic acid base pairs and triplets in tRNA tertiary interactions , 2006, Nucleic acids research.
[48] P. Sharp,et al. Recognition of cap structure in splicing in vitro of mRNA precursors , 1984, Cell.
[49] Y. Hérault,et al. A new mouse model for the trisomy of the Abcg1–U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome , 2009, Human molecular genetics.
[50] Q. Cui,et al. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features , 2016, Nucleic acids research.
[51] T. Sellers,et al. A review of the clinical relevance of mismatch‐repair deficiency in ovarian cancer , 2008, Cancer.
[52] C. Rooryck,et al. Further delineation of the phenotype caused by biallelic variants in the WDR4 gene , 2018, Clinical genetics.
[53] Jeremy E. Purvis,et al. p53 Dynamics Control Cell Fate , 2012, Science.
[54] J. Knezetic,et al. Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members. , 1999, Cancer genetics and cytogenetics.
[55] Stewart Shuman,et al. Interactions between Fission Yeast mRNA Capping Enzymes and Elongation Factor Spt5* , 2002, The Journal of Biological Chemistry.